We are live on ! Find out more
Verition Fund Management

Verition Fund Management Portfolio holdings

AUM $15.4B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
-1.45%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$1.34B
AUM Growth
+$262M
Cap. Flow
+$95.7M
Cap. Flow %
7.12%
Top 10 Hldgs %
12.32%
Holding
1,401
New
549
Increased
305
Reduced
190
Closed
310

Top Buys

Rank Stock Value
1
ETR icon
Entergy
ETR
+$22.7M
2
D icon
Dominion Energy
D
+$17.4M
3
WR
Westar Energy Inc
WR
+$11.1M
4
SRE icon
Sempra
SRE
+$11.1M
5
CI icon
Cigna
CI
+$10.6M

Sector Composition

Rank Sector Weight
1 Utilities 11.05%
2 Financials 10.47%
3 Industrials 9.71%
4 Healthcare 8.44%
5 Technology 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CASI
1026
DELISTED
CASI Pharmaceuticals
CASI
$66K ﹤0.01%
+1,584
New +$59.1K
BTG icon
1027
B2Gold
BTG
$4.98B
$60K ﹤0.01%
+21,797
New +$64.2K
CWBR
1028
DELISTED
CohBar, Inc. Common Stock
CWBR
$59K ﹤0.01%
+377
New +$67K
MRNS
1029
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$54K ﹤0.01%
+3,560
New +$84.8K
ZN
1030
DELISTED
Zion Oil & Gas, Inc.
ZN
$51K ﹤0.01%
+10,752
New +$37.3K
TLRA
1031
DELISTED
Telaria, Inc.
TLRA
$51K ﹤0.01%
+13,550
New +$58.5K
VKTX icon
1032
Viking Therapeutics
VKTX
$3.88B
$50K ﹤0.01%
+11,546
New +$63.9K
PACB icon
1033
Pacific Biosciences
PACB
$435M
$49K ﹤0.01%
+23,697
New +$61.5K
GALT icon
1034
Galectin Therapeutics
GALT
$230M
$48K ﹤0.01%
+10,195
New +$47.5K
NAGE
1035
Niagen Bioscience
NAGE
$256M
$48K ﹤0.01%
+11,416
New +$59.8K
YRIV
1036
DELISTED
Yangtze River Port and Logistics Limited Common Stock
YRIV
$47K ﹤0.01%
+11,461
New +$57.6K
CYH icon
1037
Community Health Systems
CYH
$382M
$45K ﹤0.01%
+11,425
New +$57.4K
LGC.WS
1038
DELISTED
Legacy Acquisition Corp. Warrants, exercisable for one-half of one share of Class A Common Stock for
LGC.WS
$44K ﹤0.01%
+125,354
New +$47K
ICON
1039
DELISTED
Iconix Brand Group, Inc.
ICON
$44K ﹤0.01%
4,000
+52
+1% +$699
ICON
1040
PUT
DELISTED
Iconix Brand Group, Inc.
ICON
$44K ﹤0.01%
4,000
CTIC
1041
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$44K ﹤0.01%
+11,233
New +$39.5K
OPK icon
1042
Opko Health
OPK
$1.02B
$41K ﹤0.01%
+12,848
New +$51.7K
TYME
1043
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$40K ﹤0.01%
+17,902
New +$73K
NWY
1044
DELISTED
New York & Co Inc
NWY
$40K ﹤0.01%
+11,820
New +$35.1K
EGO icon
1045
Eldorado Gold
EGO
$8.33B
$38K ﹤0.01%
+9,033
New +$52.9K
VSTM icon
1046
Verastem
VSTM
$528M
$35K ﹤0.01%
+988
New +$38.3K
APPS icon
1047
Digital Turbine
APPS
$982M
$29K ﹤0.01%
+14,342
New +$31.2K
SGYP
1048
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$25K ﹤0.01%
+13,729
New +$29K
AAL icon
1049
American Airlines Group
AAL
$9.82B
-9,623
Closed -$501K
AAP icon
1050
Advance Auto Parts
AAP
$3.53B
-4,708
Closed -$469K

Similar funds

Verition Fund Management's Q1 2018 Portfolio in Review

As of Q1 2018, Verition Fund Management held 1,401 positions worth $1.34B, up 24% from $1.08B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Verition Fund Management deployed $95.7M of net new capital in Q1 2018, opening 549 new positions and adding to 305 existing holdings. Its largest new stake was Vistra: 442,001 shares worth $9.21M.

By sector, the portfolio is most concentrated in Utilities at 11% of assets, down from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares MSCI ACWI ex US ETF, an estimated $23.4M trimmed.

  • Verition Fund Management's largest Q1 2018 buy was Vistra: 442,001 shares worth $9.21M.
  • Verition Fund Management added most to Entergy in Q1 2018, an estimated $22.7M increase.
  • Verition Fund Management's biggest Q1 2018 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $23.4M.
  • Verition Fund Management fully exited Calpine Corporation in Q1 2018, selling an estimated $49.7M.
  • Verition Fund Management's ten largest holdings make up 12% of its $1.34B portfolio in Q1 2018.
  • Verition Fund Management opened 549 new positions and closed 310 in Q1 2018.
  • Verition Fund Management's portfolio value rose 24% quarter-over-quarter to $1.34B.

Based on Verition Fund Management's 13F filing for Q1 2018, filed 16 May 2018.